Nova Ltd. (NVMI) compounding analysis
Full-size annual and quarterly year-over-year growth charts for revenue, EPS, operating cash flow, EBITDA, and free cash flow against the 15%, 20%, and 30% bars over 3-, 5-, and 10-year windows, with each metric's valuation multiple vs its own history.
Revenue · 10YDoes not currently clear the 15%+, 20%+, or 30%+ revenue bars over 10Y.
- Score
- 36/100
- 10Y CAGR
- 19.5%
- Median YoY
- 20.2%
- YoY volatility
- σ 23.1pp· choppy
- Quarters ≥ 20%
- 20 of 40
- Negative quarters
- 7
- Valuation vs own 10Y history
- P/S 14.2x · 10Y median 6.2x · 93rd percentile · as of Aug 19, 2026
How this score is computed
- Quarters at or above 20%: 20 of 40 → 20 of 40 pts
- Steadiness (typical swing 23.1pp) → 8.5 of 25 pts
- Pace (median 20.2% YoY) → 6.9 of 20 pts
- Latest quarter (15.9% YoY) → 0.7 of 15 pts
- Score: 36 of 100
Annualized revenue (TTM) · by quarter, last 40
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
Across metrics · 10Y
| Metric | 10Y CAGR | Median YoY | YoY σ | Qtrs ≥ 20% | Neg. qtrs |
|---|---|---|---|---|---|
| RevenueRevenue | 19.5% | 20.2% | 23.1pp | 20 of 40 | 7 |
| EPSEPS | 30.2% | 30.4% | 79.4pp | 21 of 39 | 9 |
| Op cash flowOperating cash flow | 25.3% | 18.7% | 112.2pp | 17 of 34 | 15 |
| EBITDAEBITDA | 29.2% | 25% | 62.3pp | 20 of 39 | 9 |
| FCFFree cash flow | 26.1% | 0% | 259.5pp | 15 of 34 | 17 |
Reported figures over 10Y: annual-series CAGR, median and standard deviation (σ, percentage points) of quarterly year-over-year growth, quarters at or above 20%, and quarters with negative YoY. “—” means the window needs more comparable data.
Scores, qualification bars, and the 0–100 consistency methodology are documented on the compounders list page →
See also: NVMI on the compounders surface · All compounders, ranked